Highlights
KLSE: DPHARMA (7148)       DUOPHARMA BIOTECH BHD MAIN : Health Care
Last Price Today's Change   Day's Range   Trading Volume
1.75   0.00 (0.00%)  1.75 - 1.78  389,800
Trade this stock with up to 3 x trading limit. Find out more.

Overview

Market Cap: 1,648 Million
NOSH: 942 Million
Avg Volume (4 weeks):744,590
4 Weeks Range:1.69 - 1.91
4 Weeks Price Volatility (%):
27.27%
52 Weeks Range:1.69 - 4.38
52 Weeks Price Volatility (%):
2.23%
Average Price Target: 1.88
Price Target Upside/Downside: +0.13
Stamp duty exempted for year 2021

Financial Highlight

Latest Quarter | Ann. Date 30-Jun-2021 [#2]  |  17-Aug-2021
Next QR | Est. Ann. Date: 30-Sep-2021  |  12-Nov-2021
T4Q P/E | EY: 26.03  |  3.84%
T4Q DY | Payout %: 2.78%  |  72.47%
T4Q NAPS | P/NAPS: 0.6523  |  2.68
T4Q NP Margin | ROE: 10.74%  |  10.31%

Headlines

Date Subject
18-Oct-2021 PublicInvest Research Headlines - 18 Oct 2021
18-Oct-2021 Mplus Market Pulse - 18 Oct 2021
18-Sep-2021 【行家论股/视频】联合药业 下半年盈利更佳
09-Sep-2021 PublicInvest Research Headlines - 9 Sept 2021
09-Sep-2021 Mplus Market Pulse - 9 Sept 2021
08-Sep-2021 Duopharma: Sinopharm vaccine distributor not determined yet
20-Aug-2021 Daily technical highlights – (DPHARMA, GAMUDA)
18-Aug-2021 【行家论股/视频】联合药业 宜趁股价调整买进
18-Aug-2021 Mplus Market Pulse - 18 Aug 2021
09-Aug-2021 准进口中国疫苗 联合药业有何利好?
19-Jul-2021 【行家论股/视频】联合药业 国药疫苗暂非政府首选
16-Jul-2021 Trading Stocks - Duopharma Biotech
10-Jun-2021 深入了解 【DPHARMA】
02-Jun-2021 PublicInvest Research Headlines - 2 Jun 2021
01-Jun-2021 Covid-19: Duopharma Biotech inks deal with Malaysian govt to supply Russia’s Sputnik V vaccine
01-Jun-2021 热门股:联合药业 上挑RM3.59
31-May-2021 大马股票 | 联合药业 | DPHARMA | 从零开始了解联合药业 - 少爷兵
20-May-2021 联合药业上挑RM3/敏源
04-May-2021 【行家论股/视频】联合药业 疫苗业务存有变数
04-May-2021 PublicInvest Research Headlines - 4 May 2021

Business Background

Duopharma Biotech Berhad, an investment holding company, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia. The company provides products in various forms, including tablets, capsules, syrups, oral antibiotics, creams, hemodialysis solutions, sterile irrigation solutions, sterile powder and small volume injectable forms, dental cartridges, and eye drop preparations. It offers generic and halal pharmaceutical products; and over-the-counter products primarily under the Champs, Flavettes, Proviton, Naturalle, Uphamol, Eye Glo, Donna, and Alucid brands, as well as analgesics, antihistamines, etc. The company also operates under the OMESEC brand name. In addition, it is also involved in the property management activities; and distribution of chemical products. Duopharma Biotech Berhad also exports its products to Vietnam, Ethiopia, Sudan, Southeast Asia, Papua New Guinea, Pakistan, Bangladesh, Sri Lanka, the Republic of Yemen, Singapore, and Hong Kong. The company was formerly known as CCM Duopharma Biotech Berhad and changed its name to Duopharma Biotech Berhad in February 2019. The company was founded in 1979 and is based in Klang, Malaysia. Duopharma Biotech Berhad is a subsidiary of Permodalan Nasional Berhad.
Analyze this stock with MQ Trader system

  12 people like this.
 
433tikitaka the most lousy director. all cb malas
24/09/2021 10:47 AM
433tikitaka talk cock kahwin baru talk cock kahwin baru
24/09/2021 10:47 AM
433tikitaka that only they know
24/09/2021 10:47 AM
433tikitaka then wear blazer can become datuk already. work dont know how to do. 1 whole year no show this counter
24/09/2021 10:48 AM
433tikitaka pharma superb
24/09/2021 10:48 AM
Trevor777 No doubt Dpharma is a laggard. Absolutely right on this claim.

But, may we know how great is Pharma? Investors still trapped at 7.00, high of 7.25 and ex bonus at 5.25 (1.05 on 4 : 1 bonus) Current price at 81c (4.05 pre-bonus)

That's a drop from 7.25 to 4.05!!!!

You need to get your head checked.
26/09/2021 9:37 AM
Keyman188 Keyman188 might be considered to bet in if the share price dip below what highlighted earlier @ 1.50...


Otherwise Keyman188 no hurry to keep stuff at fridge...


Wkwkwk...kekeke...hehehe...





Posted by Keyman188 > Sep 8, 2021 9:17 PM | Report Abuse 

Further reminder before making any further decision...


Non-growth stock...(not consistent growth...no matter EBITDA or NP to SH not consistent for the past 5 years)...


Non-value stock...(current share price consider high valuation due to high PE by around 27 times)...


Latest financial performance NOT so excited...


QoQ revenue decelerated by 6.62%

QoQ net profit decelerated by 12.63%



"We retain our SELL call on the stock with an unchanged TP of RM2.00 (ex-bonus : RM1.50) based on a CY22F P/E of 20 times (+1 standard deviations from its five-year mean),” the Keyman188 research house highlighted.
26/09/2021 9:57 AM
Kicimeow Go to sleep la
26/09/2021 10:54 AM
Lightofheaven Industry of medicine is like a steel bowl.
Put ur money here wont regret.
27/09/2021 10:25 PM
790574 agreed 433tikikata needs to get his head fixed.
28/09/2021 11:37 PM
gohkimhock good counter but price keeps on falling for no reasons.
30/09/2021 7:20 PM
433tikitaka really cb talk cock director mia. hahahahaahha
01/10/2021 12:03 PM
433tikitaka malas malas malas malas malas and talk cock again
01/10/2021 12:04 PM
433tikitaka pharma very good oh. almost 1 year this cb stock never go up.whyy? malas director tidur only. talk cock kahwin baru
01/10/2021 12:05 PM
433tikitaka see like Pharma. Go fly many2 times. Very good director and company.
01/10/2021 12:06 PM
Keyman188 Further notification...


Keyman188 might be considered to bet in if the share price dip below what highlighted earlier @ 1.50...


Otherwise Keyman188 no hurry to keep stuff at fridge...


Wkwkwk...kekeke...hehehe...





Posted by Keyman188 > Sep 8, 2021 9:17 PM | Report Abuse

Further reminder before making any further decision...


Non-growth stock...(not consistent growth...no matter EBITDA or NP to SH not consistent for the past 5 years)...


Non-value stock...(current share price consider high valuation due to high PE by around 27 times)...


Latest financial performance NOT so excited...


QoQ revenue decelerated by 6.62%

QoQ net profit decelerated by 12.63%



"We retain our SELL call on the stock with an unchanged TP of RM2.00 (ex-bonus : RM1.50) based on a CY22F P/E of 20 times (+1 standard deviations from its five-year mean),” the Keyman188 research house highlighted.
01/10/2021 12:09 PM
Keyman188 Finally break below 1.80 liao...

Amboi...kesian nya....
01/10/2021 5:01 PM
Tyeo0313 Anyone know whoch pharmaceutical company is going to acquired merck's covid 19 pills ?
02/10/2021 8:51 PM
vjn86 https://www.astroawani.com/video-dunia/vaksin-covid-19-who-tarik-sekatan-bagi-penggunaan-sputnik-v-1926228
03/10/2021 10:35 AM
almond Keep drop like shit. Profit company also drop wiyhout reason rrs keep boom
04/10/2021 11:52 AM
MYthenightmare Rotten backdoor gov together with treacherous managements and operators have dragged this M country to hell.
04/10/2021 12:58 PM
Lightofheaven Buy more and wait patiently
05/10/2021 11:53 AM
almond Lol. You can buy in dip means share keep drop, once buy in in downtrend, it will keep drop, and no idea why they keeo sell in low prices or drop
05/10/2021 12:08 PM
433tikitaka malas director lah. hahaha 1 year cb no show. vaccine 90% already
05/10/2021 2:58 PM
433tikitaka what cb management know is malas, talk cock, wear blazer and kahwin baru only.
05/10/2021 2:59 PM
Keyman188 Really laugh die Keyman188...

Keyman188 still can recalled...

You keep on asking to buy during the share price above 2.85 (before bonus issue)...

Right now you keep on blaming the co. management...

Keyman188 already highlighted to you all...

Below RM 1.50 shall be consider to bet in...


Amboi + Adui...



wkwkwk...kekeke...hehehe...






Posted by 433tikitaka > Oct 5, 2021 2:58 PM | Report Abuse

malas director lah. hahaha 1 year cb no show. vaccine 90% already


Posted by 433tikitaka > Oct 5, 2021 2:59 PM | Report Abuse

what cb management know is malas, talk cock, wear blazer and kahwin baru only.


Posted by 433tikitaka > Jun 1, 2021 10:54 AM | Report Abuse

TP RM 8.0. If more then that, bonus. DPHARMA have really good fundamental


Posted by 433tikitaka > Jun 1, 2021 10:53 AM | Report Abuse

My advice to you guys, enter now. This counter will blow up, 2021 is vaccination year. All the best


Posted by 433tikitaka > May 20, 2021 11:00 AM | Report Abuse

good future
05/10/2021 3:07 PM
Apple2353 biasa lah.. when counter active and going up, the call is BUY. When go down.. its because of lazy CB DIRECTORS.
05/10/2021 3:30 PM
Keyman188 So...

Dump lahhh...
05/10/2021 4:03 PM
Mabel No power
05/10/2021 8:10 PM
vjn86 Steady, Mabel dah masuk. Meow...
06/10/2021 1:09 AM
Valgrovest EPF continued tp buy as they are of the view that the share is undervalue.
07/10/2021 3:43 PM
Consultant Will drop below rm1..
07/10/2021 5:58 PM
Valgrovest Going uptrend already today. Once the distribution of Sputnix start, will limit up.
08/10/2021 4:18 PM
BennyWhittman Post removed. Why?
09/10/2021 8:35 AM
BennyWhittman @Consultant....are you for real? Your degree from Tanjung Rambutan madhouse?

These people here are just so F%$^king hopeless and brain dead. No wonder this stock stays where it is ALL THE TIME.
09/10/2021 8:38 AM
BennyWhittman Post removed. Why?
09/10/2021 9:28 AM
433tikitaka told you this cb director all malas one. hahaha cb very funny 1 year no show. dont wasting time here. go pharmaniaga
11/10/2021 12:16 PM
433tikitaka cb malas, malas dont handle big company lah. useless
11/10/2021 12:16 PM
DrMichael Incidentally, didn't those poor folks over at Pharma had their viens sliced and bleeding out? Pharma's Bonus was to play from 3.20 to 7.25, and dumped until cum bonus at 5.25? At ex bonus price of 1.05 been drying up until 82 sens currently. So, that counter is a much more profitable PLC that this one? How so, may we know?

Please take some time to explain explicitly as we are not entirely following your call to migrate there.
13/10/2021 10:10 PM
DrMichael Oh, and your unkind use of profanities. Wasn't that hot-head Benny just suspended and messages deleted for excessive use of the F words? Why are the Admin having double standard, I wonder.
13/10/2021 10:11 PM
DrMichael And if you're suffering from PTSD, I could recommend a few Specialist to help you. NO? Are you sure you don't need help?
13/10/2021 10:14 PM
Valgrovest https://www.theedgemarkets.com/article/sinopharm-covid19-vaccine-now-available-malaysia

This will boost the business of Dpharma !
15/10/2021 2:35 PM
nicholas99 goyang style ceo.
15/10/2021 6:05 PM
Sioksiok19 oyang goyang then suddenly limit up when approval for sputnik obtained........
15/10/2021 10:42 PM
DrMichael Are you certain Sputnik would be NPRA approved? Isn't the Vaccine play already all over? Malaysia has achieved 90% Vaccination rate and most like a booster for some. Where's the Quantative volume? What's the Profit Margins, isn't a fine fee usually?

By the time even Sinopharm is hitting the Private Clinics and Hospitals, there could be no margins or too little to impact bottom line of Dpharm with small dripping supplies accorded to Dpharma.

A dollar short and a day late....usual story of Dpharma.
16/10/2021 10:05 AM
DrMichael Moreover, the price unable to stand at Ex-Bonus 1.96 has completely cancelled out the 33.3% gains from the Bonus. What a way to capture investors interest and swing up to 3.60 pre-BI play. dare say, those still holding are caught holding and dumped in fridge now.

Lesson...Never trust a GLC for their Bonuses. They take more than they give. Or at least the institutions do.
16/10/2021 10:05 AM
Valgrovest There is no sight that the virus is going to die off but rather here to stay. Under the circumstance, the only way to safeguard ourselves is via vaccine, vaccine, vaccine, booster (also vaccine), another booster (vaccine).....Same with other countries in every parts of the world. The world cannot live without vaccine until the day the virus can be completely eradicated which is still a big question mark. Hence the business of all vaccine producers and distributors and their agents will remain sustainable.
16/10/2021 11:19 PM
DrMichael Such an equation of Dpharma to the never ending great profits from vaccines and yet what has it been with Pharma, which had already done more than 14.5 million doses and 3 million on book order from MOH?

Dpharma has been allocated the License Registration for Sputnik, how long ago? Probably, just some candies to pacify the shareholders. And how many doses of Sinopharm was allocated after this License? 3.2 million doses? And how much do you think Dpharma can possibly make in terms of Net profits at 2%-3% charges?

These people whom are talking with parabole of Dpharma is as profitable as the Vaccine REAL MANUFACTURERS and producers, should be mask taped because it's all nonsense. Their schematics are to cloud the real profit margins and promote false earnings.

In a single sentence, this writer is saying Virus will not disappear from the world, conjoined with Dpharma as the PRODUCER and their vaccines are needed all over the world for all eternity?

Please be reminded Malaysia has only 33 million populations and there are more than 4 brands of Vaccines approved.
17/10/2021 12:18 PM
DrMichael It is incomprehensible how some people promotes vaccine plays like selling Insurance. Similarly, a Convenient Store selling canned Cokes are as profitable as the Coke Franchise holder or the soft drink manufacturer?
17/10/2021 4:02 PM
BursaRangers https://klse.i3investor.com/blogs/BursaRangersTechnicalPicks/2021-10-17-story-h1592740837-BursaRangers_Daily_Technical_Picks_18_October_2021.jsp
17/10/2021 8:35 PM


FEATURED POSTS

1. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!
APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Earn MQ Points while trading with MQ Traders Group
MQ Affiliate
Earn side income from MQ Affiliate Program
 
 

446  477  595  768 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 MACPIE 0.13+0.025 
 JOE 0.0450.00 
 JOE-WB 0.0150.00 
 TIGER 0.045+0.005 
 MTOUCHE 0.11+0.005 
 KNM 0.2250.00 
 MYEG 1.05-0.01 
 MAG 0.215+0.01 
 CEKD 1.03+0.075 
 BINTAI 0.43+0.05 
PARTNERS & BROKERS